US cancer institute funds trial of complementary therapyBMJ 2000; 320 doi: https://doi.org/10.1136/bmj.320.7251.1690/a (Published 24 June 2000) Cite this as: BMJ 2000;320:1690
- Deborah Josefson
- San Francisco
The US National Cancer Institute, through its office of Complementary and Alternative Medicine, is funding phase III clinical trials of a controversial treatment for advanced pancreatic cancer.
The treatment protocol, the Gonzalez regimen, involves a programme of dietary modification, nutritional supplements, and “detoxification” through coffee enemas. Patients with stage II-IV pancreatic cancer are being enrolled.
The study was initially established in 1993, when Dr Nicholas Gonzalez submitted selected unpublished results of his cancer therapy to the National Cancer Institute. The initial cohort involved 11 patients with diverse cancers who were treated with his regimen.
Anecdotal evidence …